Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1330463
European Journal of Endocrinology, Vol 133, Issue 4, 463-464
Copyright © 1995 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olukoga, A. O
Right arrow Articles by Kane, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Olukoga, A. O
Right arrow Articles by Kane, J.

Anti-prolactin autoantibodies and hyperprolactinaemia

Adebayo O Olukoga and John Kane

Recent reports by Hattori et al. (1, 2) provide evidence for immunoglobulin binders of prolactin, i.e. anti-prolactin autoantibodies, as a cause of hyperprolactinaemia. Specific assays for rapid identification of anti-prolactin autoantibodies are currently unavailable, but the polyethylene glycol (PEG) precipitation screening test combined with measurement of free prolactin as detailed by Hattori et al. (1, 2) has been proposed as a first-line evaluation of suspected cases of anti-prolactin autoantibody-induced hyperprolactinaemia (3). It has also been proposed that laboratories providing a prolactin assay service may be required to offer routine anti-prolactin autoantibody measurements (3).

We screened 86 serum samples in duplicate for anti-prolactin autoantibodies using the PEG precipitation method. The samples were selected from among those received in our laboratory for routine measurement of prolactin. Fifty-one of these sera had elevated prolactin concentrations (> 420 mU/l; range 434–17 000) while 35 had normal concentrations. For the PEG screening test, 100 µl




This article has been cited by other articles:


Home page
EndocrinologyHome page
N. Hattori, Y. Nakayama, K. Kitagawa, T. Li, and C. Inagaki
Development of Anti-PRL (Prolactin) Autoantibodies by Homologous PRL in Rats: A Model for Macroprolactinemia
Endocrinology, May 1, 2007; 148(5): 2465 - 2470.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Hattori, K. Ikekubo, Y. Nakaya, K. Kitagawa, and C. Inagaki
Immunoglobulin G Subclasses and Prolactin (PRL) Isoforms in Macroprolactinemia Due to Anti-PRL Autoantibodies
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3036 - 3044.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Leslie, C. H. Courtney, P. M. Bell, D. R. Hadden, D. R. McCance, P. K. Ellis, B. Sheridan, and A. B. Atkinson
Laboratory and Clinical Experience in 55 Patients with Macroprolactinemia Identified by a Simple Polyethylene Glycol Precipitation Method
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2743 - 2746.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 European Society of Endocrinology.